Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Sep. 28, 2013	Sep. 29, 2012	Oct. 01, 2011
OPERATING ACTIVITIES:
Net income	$ 5,067,417	$ 5,214,973	$ 3,699,066
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	775,767	756,656	720,478
Amortization	509,247	452,670	89,218
Provision for losses on accounts receivable	91,623	32,008	36,936
Provision (Benefit) for deferred income taxes	166,000	(66,000)	164,000
Gain on sale and disposal of property and equipment	(916)
Increase in cash value of life insurance	(184,786)	(194,806)	(11,848)
Deferred compensation	(20,048)	(54,705)	(51,626)
Stock compensation expense	34,242	72,264	69,497
Changes in operating assets and liabilities:
Accounts receivable	295,550	(69,307)	741,736
Inventories	2,898,492	520,981	(3,534,362)
Prepaid expenses and other assets	(296,204)	256,544	441,060
Accounts payable and accrued and sundry liabilities	(1,117,533)	(55,964)	633,221
Net cash provided by operating activities	8,218,851	6,865,314	2,997,376
INVESTING ACTIVITIES:
Acquisition of M.C. Healthcare		(8,251,831)
Purchases of securities available for sale			(2,760,000)
Proceeds from sale of securities available for sale		4,000,000	2,460,000
Purchases of property and equipment	(557,863)	(684,327)	(191,209)
Proceeds from sale of property and equipment	7,850
Payments for other assets	(110,586)	(107,528)	(102,665)
Net cash used for investing activities	(660,599)	(5,043,686)	(593,874)
FINANCING ACTIVITIES:
Dividends paid	(4,439,382)	(1,358,425)	(1,166,789)
Proceeds from long-term debt		9,300,000
Repayment of long-term debt		(9,300,000)
Purchase and retirement of common stock	(450,000)		(8,292)
Proceeds from exercise of options for common stock	152,647	68,946	114,790
Net cash used for financing activities	(4,736,735)	(1,289,479)	(1,060,291)
Effect of exchange rates on cash	(62,298)	8,747
Increase in cash and cash equivalents	2,759,219	540,896	1,343,211
Cash and cash equivalents at beginning of year	2,665,302	2,124,406	781,195
Cash and cash equivalents at end of year	$ 5,424,521	$ 2,665,302	$ 2,124,406